Karma Biotechnologies

United States
Torrance, California, United States, 90501

Company profile

Karma Biotechnologies company profile

Karma Biotechnologies is a Los Angeles startup dedicated to solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform. General immune suppression is still the standard of care for most autoimmune disease patients; there is a critical unmet need to develop antigen-specific therapies that inhibit only the disease-causing rogue immune cells. To meet this need, Karma is leveraging expertise in immunology and lipid nanoparticle engineering to develop tolerogenic immunotherapies that elicit antigen-specific immune tolerance in vivo.

Business identity

Contact email
[email protected]
Phone number
8183966373
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-03-21

Headquarters

Postal code
90501
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$4.9M
Last funding
Seed / 2023-05-31
Last equity funding
Seed
Investors
10
Lead investors
2
Founders
3

Founders and investors

Founders

Alan JohnsonAndrew GrayDon Johnson

Lead investors

Khosla VenturesSOSV

Investors

GaingelsKhosla VenturesPresight CapitalSOSVTuesday Capital